UnitedHealth Group (UNH) Q3 2026 Earnings Call: EPS Guidance Raised to at Least $20.50
Source Tradingkey
Core Takeaways
- UnitedHealth Group reported Q3 2026 revenue of $113 billion and adjusted EPS of $4.69, up from $2.92 a year earlier.
- The consolidated medical care ratio improved to 88.4% from 89.9% in Q3 2025, reflecting pricing discipline, medical cost management and care delivery improvements.
- Management raised full-year 2026 adjusted EPS guidance to at least $20.50 and described that level as a solid base for future growth.
- Medicare performance improved, with management now expecting 2026 margins near the top of the previously cited 2%–4% range. Core Medicaid margins are expected to be moderately better than negative 1%.
- Management said the lower end of UnitedHealth Group’s long-term 13%–16% earnings growth target is a more reasonable starting point for 2027 than current expectations, while noting continued medical-cost and funding pressures.
- AI and modernization initiatives are producing measurable operating benefits: AI-enabled chart summaries cover more than 40% of employed clinicians and have reduced chart-review time by 33%, while AI-supported information gathering has shortened appeal cycles by 26%.
Key Financial Data
| Metric | Q3 2026 / 2026 update | Comparison or context |
|---|---|---|
| Revenue | $113 billion | Q3 2026 |
| Adjusted EPS | $4.69 | Up from $2.92 a year earlier |
| Consolidated medical care ratio | 88.4% | Improved from 89.9% a year earlier |
| Full-year adjusted EPS guidance | At least $20.50 | Updated after Q3 results |
| Debt-to-capital ratio | 41.7% | Management expects it to approach 40% by year-end |
| Share repurchases | $5 billion | Through Q3 2026 |
| Dividends paid | $6.2 billion | Year to date; expected to exceed $8 billion by year-end |
Business and Operating Performance
UnitedHealthcare
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Recommended Articles
Imminent CPI and PPI data threaten to lock in a hawkish Federal Reserve rate hike cycle, leaving gold, tech equities, and Bitcoin highly vulnerable to a programmatic sell-off.
XRP (XRP) price trades near $1.05, caught between a year-long downtrend and a sudden burst of buying.July has historically rewarded XRP holders. This year the month arrives with on-chain accumulation
Gold holds above $4,350 following weak US jobs data. As inflation reports approach and UBS eyes $5,000, can XAUUSD break resistance at $4,435 to rally toward $4,500?
Gold Price Analysis Today: Gold Drops 1.32% Despite Lower Fed Rate-Hike Bets, Can $4,313 Support Hold?
Gold fell 1.32% on August 13 after rising to $4,449.73, then reversing lower and closing near $4,349.918 below the $4,356.46 support. Softer US inflation data reduced Fed rate hike expectations, but selling pressure still dominated the session. Will $4,313 support hold?
Gold fell 1.32% on August 13 after rising to $4,449.73, then reversing lower and closing near $4,349.918 below the $4,356.46 support. Softer US inflation data reduced Fed rate hike expectations, but selling pressure still dominated the session. Will $4,313 support hold?
Gold Price Analysis Today: Gold Gains 0.94% as Markets Expect Fed to Hold Rates, Can $4,449 Resistance Break?
Gold gained 0.94% on August 17, closing near $4,417.30 as softer US data strengthened expectations for unchanged Fed rates in September. Gold remains bullish, with $4,449.730 resistance and $4,310.650 support in focus.
Gold gained 0.94% on August 17, closing near $4,417.30 as softer US data strengthened expectations for unchanged Fed rates in September. Gold remains bullish, with $4,449.730 resistance and $4,310.650 support in focus.
